Bempedoic acid
Таблетки, покрытые пленочной оболочкойATP-citrate lyase inhibitor – the first oral hypolipidemic drug of a new class for lowering LDL-C levels – “not a statin”
Indications
Bempedoic acid is indicated for the treatment of adult patients with primary hyper-cholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia as an addition to the diet:
• in combination with drugs of the statin group or statins used in conjunction with other hypolipidemic drugs in patients unable to achieve target low-density lipoprotein cholesterol levels;
• as monotherapy or in combination with other hypolipidemic drugs in patients with intolerance to statins or in patients for whom they are contraindicated.
If there is no improvement or you feel worsening, you should consult a doctor.
Contraindications
Do not take Bempedoic acid:
- if you are allergic to bempedoic acid or any other ingredients of the drug listed in section 6 of the package insert sheet;
- if you are pregnant;
- if you are breast-feeding;
- if you are taking simvastatin (a medicine from the group of statins used to lower bad cholesterol in the blood) in doses of more than 40 mg per day.
Usage
Always take this medicine in full accordance with the advice of your doctor. If in doubt, consult your doctor.
Recommended dose
The recommended dose of Bempedoic acid is one film-coated tablet (180 mg) once a day.
If you are prescribed concomitant use of Bempedoic Acid and simvastatin, the recommended dose of simvastatin is 20 mg daily. Your doctor may increase your simvastatin dose to 40 mg per day depending on your condition.
If you have serious kidney or liver problems your doctor will monitor your condition. You may be prescribed additional tests.
Have questions? Contact Us
Drugs in the category Cardiology
Has contraindications. Needs specialist overview.